AU1769297A - Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology - Google Patents

Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology

Info

Publication number
AU1769297A
AU1769297A AU17692/97A AU1769297A AU1769297A AU 1769297 A AU1769297 A AU 1769297A AU 17692/97 A AU17692/97 A AU 17692/97A AU 1769297 A AU1769297 A AU 1769297A AU 1769297 A AU1769297 A AU 1769297A
Authority
AU
Australia
Prior art keywords
pharmaceutical agents
metal complexes
interventional radiology
tumour therapy
agents containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17692/97A
Inventor
Thomas Frenzel
Ulrich Niedballa
Johannes Dr. Platzek
Bernd Dr. Raduchel
Wolfgang Schlecker
Hanns-Joachim Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU1769297A publication Critical patent/AU1769297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to pharmaceutical agents containing perfluoroalkylated metal complexes of the general formula (I) RF-L-A and the use thereof in tumour therapy and interventional radiology, in which formula RF is a perfluorinated, straight-chain or branched carbon chain with the formula -CnF2nX, in which X is a terminal fluorine, chlorine, bromine, iodine or hydrogen atom and n represents the numbers 4-30, L is a binding group, and A is a metal complex or the salts thereof of organic and/or inorganic bases or amino acids or amino acid amides. L and A are defined in detail in the description.
AU17692/97A 1996-02-23 1997-02-14 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology Abandoned AU1769297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19608278A DE19608278A1 (en) 1996-02-23 1996-02-23 Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology
DE19608278 1996-02-23
PCT/EP1997/000684 WO1997030969A1 (en) 1996-02-23 1997-02-14 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology

Publications (1)

Publication Number Publication Date
AU1769297A true AU1769297A (en) 1997-09-10

Family

ID=7787153

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17692/97A Abandoned AU1769297A (en) 1996-02-23 1997-02-14 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology

Country Status (14)

Country Link
EP (1) EP0882010B1 (en)
JP (1) JP2000504736A (en)
AT (1) ATE200894T1 (en)
AU (1) AU1769297A (en)
CA (1) CA2247253A1 (en)
DE (2) DE19608278A1 (en)
DK (1) DK0882010T3 (en)
ES (1) ES2158493T3 (en)
GR (1) GR3036306T3 (en)
NO (1) NO323547B1 (en)
PT (1) PT882010E (en)
TW (1) TW477699B (en)
WO (1) WO1997030969A1 (en)
ZA (1) ZA971537B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919433A (en) * 1996-12-04 1999-07-06 Schering Aktiengesellschaft Macrocyclic metal complex carboxylic acids, their use as well as process for their production
DE19729013A1 (en) * 1997-07-03 1999-02-04 Schering Ag Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics
DE19731591C2 (en) * 1997-07-17 1999-09-16 Schering Ag Pharmaceutical compositions containing triiodoaromatics containing perfluoroalkyl groups and their use in tumor therapy and interventional radiology
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
DE19914101C1 (en) * 1999-03-22 2000-10-12 Schering Ag Perfluoroalkylamides, their preparation and their use in diagnostics
US6676928B2 (en) 2000-08-11 2004-01-13 Schering Aktiengesellschaft Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
DE10040858C2 (en) * 2000-08-11 2003-12-18 Schering Ag Perfluoroalkyl-containing complexes with polar residues, process for their preparation and their use
CA2456052A1 (en) 2001-08-03 2003-02-20 Glaxo Group Limited Surfactant compounds and uses thereof
WO2004006934A2 (en) * 2002-07-10 2004-01-22 Hans Robert Kalbitzer 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
DE102005008309A1 (en) * 2005-02-17 2006-08-24 Schering Ag Pharmaceutical agents containing fluoroalkyl-containing metal complexes and epothilones
ITMI20131225A1 (en) * 2013-07-22 2015-01-23 Miteni Spa NEW FLUORURED ORGANIC COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATE SUMMARY
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
MX2021006024A (en) 2018-11-23 2021-07-06 Bayer Ag Formulation of contrast media and process of preparation thereof.
JP2024020674A (en) * 2021-01-06 2024-02-15 Ａｇｃ株式会社 peptide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803869C2 (en) * 1978-01-30 1983-12-29 Ethicon, Inc., 08876 Somerville, N.J. Injectable embolization and occlusion solution
JPS59130813A (en) * 1983-01-14 1984-07-27 Green Cross Corp:The Adminiculum for chemotherapy of cancer
JPS59130812A (en) * 1983-01-14 1984-07-27 Green Cross Corp:The Adminiculum for chemotherapy of cancer
JP2657393B2 (en) * 1988-05-18 1997-09-24 日本化薬株式会社 Chemoembolization agent
FR2682110B1 (en) * 1991-10-02 1995-05-24 Atta PERFLUOROALKYL AMPHIPHILIC LIGANDS, THEIR METAL COMPLEXES AND THEIR USES IN PREPARATIONS FOR THERAPEUTIC USE.
WO1993018795A1 (en) * 1992-03-19 1993-09-30 Daikin Industries, Ltd. Mri contrast medium and diagnostic method
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same

Also Published As

Publication number Publication date
DE59703468D1 (en) 2001-06-07
DK0882010T3 (en) 2001-08-20
CA2247253A1 (en) 1997-08-28
ZA971537B (en) 1997-10-30
PT882010E (en) 2001-10-30
EP0882010B1 (en) 2001-05-02
TW477699B (en) 2002-03-01
GR3036306T3 (en) 2001-10-31
JP2000504736A (en) 2000-04-18
WO1997030969A1 (en) 1997-08-28
DE19608278A1 (en) 1997-08-28
NO983875L (en) 1998-10-22
ES2158493T3 (en) 2001-09-01
NO323547B1 (en) 2007-06-11
ATE200894T1 (en) 2001-05-15
EP0882010A1 (en) 1998-12-09
NO983875D0 (en) 1998-08-21

Similar Documents

Publication Publication Date Title
AU1769297A (en) Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology
AU3262597A (en) Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
NO954440L (en) 2 pyridylmethylene polyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
AU7305196A (en) Compound on a base of nitrogen monoxide used as a medication
AU8623698A (en) Perfluoroalkylated oligomer compounds, process for preparing the same and their use in nmr diagnosis
EP0738142A4 (en) Perfluorocarbons as anti-inflammatory agents
GB9308957D0 (en) Novel produgs
GEP20022654B (en) Indazole Amide Compounds As Serotoninergic Agents
KR910007858A (en) S (+)-Ibuprofen-L-amino acids and S (+)-Ibuprofen-D-amino acids as early-promoting and enhanced analgesics
TW326386B (en) Novel acaricidally active tetrazine derivatives
AU6698894A (en) 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
EP0486045A3 (en) S(+)-phenyl-alkanoic acids and alpha-amino acid containing complexes
AU8625598A (en) Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
AU3194784A (en) Benzoic acid derivatives
DK492989D0 (en) AMINOPYRROLIDINON, PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION AND PROCEDURE FOR PRODUCING THEREOF
WO1998038994A3 (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
PT876144E (en) "THERAPEUTIC AGENTS, CONTAINING EBSELEN AGAINST ASTHMA"
AU2049995A (en) Tumor affinity peptide, and radioactive diagnostic agent and adioactive therapeutic agent containing the peptide
GR3023896T3 (en) 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof.
Tavares et al. Spectroscopic studies on fully oxidized and semi-reduced desulfoferrodoxin purified from Desulfovibrio desulfuricans ATCC 27774
AU572374B2 (en) Azolyl-aroxymethyl-dimethylpentinols, their use as fungicides
EP0284069A3 (en) Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses
Boreham Intramolecular Hydrolysis of Glycine Derivatives Coordinated to Cobalt (III) and Some Aspects of Iron Porphyrins Containing Attached Sulphur Groups
TH17660EX (en) Mixture for the prevention and treatment of myopia
TH17660A (en) Mixture for the prevention and treatment of myopia